Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder

Por Savitz, Jonathan, Dantzer, Robert, Wurfel, Brent E., Victor, Teresa A., Ford, Bart N., Bodurka, Jerzy, Bellgowan, P.S.F, Teague, T. Kent, Drevets, Wayne C.
Publicado no Psychoneuroendocrinology (2014)

Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder

Por Savitz, Jonathan, Drevets, Wayne C., Wurfel, Brent E., Ford, Bart N., Bellgowan, Patrick S.F., Victor, Teresa A., Bodurka, Jerzy, Teague, T. Kent, Dantzer, Robert
Publicado no Brain Behav Immun (2015)

Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder

Por Meier, Timothy B., Drevets, Wayne C., Wurfel, Brent E., Ford, Bart N., Morris, Harvey M., Victor, Teresa A., Bodurka, Jerzy, Teague, T. Kent, Dantzer, Robert, Savitz, Jonathan
Publicado no Brain Behav Immun (2015)

Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder

Por Savitz, Jonathan, Dantzer, Robert, Meier, Timothy B., Wurfel, Brent E., Victor, Teresa A., McIntosh, Scott A., Ford, Bart N., Morris, Harvey M., Bodurka, Jerzy, Teague, T. Kent, Drevets, Wayne C.
Publicado no Psychoneuroendocrinology (2015)